التفاصيل البيبلوغرافية
| العنوان: |
The Use of Celecoxib for Reduction of Pain After Subpectoral Breast Augmentation. |
| المؤلفون: |
Parsa, Alan A., Soon, Christopher W. M., Don Parsa, Fereydoun |
| المصدر: |
Aesthetic Plastic Surgery; Nov/Dec2005, Vol. 29 Issue 6, p441-444, 4p |
| مصطلحات موضوعية: |
CELECOXIB, PAIN management, AUGMENTATION mammaplasty, DRUG dosage, PLACEBOS, OPIOIDS |
| مستخلص: |
A study was conducted to determine whether a single 400-mg dose of oral celecoxib administered 30 min before surgery reduces the opioid requirement for patients undergoing aesthetic subpectoral breast augmentation. A total of 695 patients undergoing breast augmentation were randomly selected into either a placebo or a treatment group. The findings showed that patients who received 400 mg of celecoxib 30 min before surgery required significantly fewer opioid analgesics after the operation than those given a placebo ( p < 0.001). It also was found that nonsmokers and multiparous women required significantly fewer opioids than smokers and nulliparous women ( p < 0.001). On the basis of this prospective study, the authors recommend a single 400-mg dose of celecoxib administered 30 min before surgery to decrease opioid analgesic requirements after subpectoral breast augmentation. [ABSTRACT FROM AUTHOR] |
|
Copyright of Aesthetic Plastic Surgery is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
